Novartis to feature new PNH and CML scientific data from broad hematology portfolio at European Hematology Association Annual MeetingGlobeNewsWire • 05/11/23
Just - Evotec Biologics Launches Tech Partnership for Biosimilars Development and Commercial ManufacturingAccesswire • 05/09/23
Novartis to present new data across oncology portfolio including Kisqali Phase III NATALEE trial in early breast cancer at ASCOGlobeNewsWire • 04/26/23
Novartis Phase III APPOINT-PNH trial shows investigational oral monotherapy iptacopan improves hemoglobin to near-normal levels, leading to transfusion independence in all treatment-naïve PNH patientsGlobeNewsWire • 04/26/23
Novartis Extends Breakout As Three Key Drivers Lead To A Beat-And-RaiseInvestors Business Daily • 04/25/23
Novartis delivers strong sales growth, robust margin expansion and major innovation milestones. Raises FY guidanceGlobeNewsWire • 04/25/23
Novartis presents new five-year data on disability outcomes and safety of Kesimpta® (ofatumumab) in people living with relapsing multiple sclerosisGlobeNewsWire • 04/20/23
5 European Dividend Aristocrats Offer Huge Growth and Income Potential With Diversification From the US24/7 Wall Street • 04/13/23
Why 7 of the Highest-Yielding ‘Strong Buy' Health Care Stocks Are the Absolute Best 2023 Buys24/7 Wall Street • 04/12/23